{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,3,26]],"date-time":"2025-03-26T06:01:43Z","timestamp":1742968903407,"version":"3.40.3"},"publisher-location":"Cham","reference-count":88,"publisher":"Springer International Publishing","isbn-type":[{"type":"print","value":"9783030619800"},{"type":"electronic","value":"9783030619817"}],"license":[{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2020]]},"DOI":"10.1007\/978-3-030-61981-7_24","type":"book-chapter","created":{"date-parts":[[2020,11,21]],"date-time":"2020-11-21T14:02:52Z","timestamp":1605967372000},"page":"436-459","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Novel Diagnostic and Therapeutic Immunologic Strategies to Overcome Infectious, Oncologic and Neurodegenerative Disorders"],"prefix":"10.1007","author":[{"given":"F.","family":"Aires-da-Silva","sequence":"first","affiliation":[]},{"given":"J.","family":"Dias","sequence":"additional","affiliation":[]},{"given":"S. I.","family":"Aguiar","sequence":"additional","affiliation":[]},{"given":"F.","family":"Marques","sequence":"additional","affiliation":[]},{"given":"A.","family":"Andr\u00e9","sequence":"additional","affiliation":[]},{"given":"S.","family":"Gil","sequence":"additional","affiliation":[]},{"given":"L.","family":"Tavares","sequence":"additional","affiliation":[]}],"member":"297","published-online":{"date-parts":[[2020,11,22]]},"reference":[{"key":"24_CR1","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.nbd.2009.07.030","volume":"37","author":"NJ Abbott","year":"2010","unstructured":"Abbott, N.J., Patabendige, A.A.K., Dolman, D.E.M., Yusof, S.R., Begley, D.J.: Structure and function of the blood-brain barrier. Neurobiol. Dis. 37, 13\u201325 (2010)","journal-title":"Neurobiol. Dis."},{"key":"24_CR2","doi-asserted-by":"publisher","first-page":"1201","DOI":"10.1111\/j.1471-4159.2005.03463.x","volume":"95","author":"A Abulrob","year":"2005","unstructured":"Abulrob, A., Sprong, H., Van Bergen en Henegouwen, P., Stanimirovic, D.: The blood-brain barrier transmigrating single domain antibody: mechanisms of transport and antigenic epitopes in human brain endothelial cells. J. Neurochem. 95, 1201\u20131214 (2005)","journal-title":"J. Neurochem."},{"key":"24_CR3","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1016\/j.hoc.2012.02.013","volume":"26","author":"MJ Adler","year":"2012","unstructured":"Adler, M.J., Dimitrov, D.S.: Therapeutic antibodies against cancer. Hematol. Oncol. Clin. North Am. 26, 447\u2013481 (2012)","journal-title":"Hematol. Oncol. Clin. North Am."},{"key":"24_CR4","doi-asserted-by":"publisher","first-page":"301","DOI":"10.2165\/00063030-200822050-00003","volume":"22","author":"F Aires da Silva","year":"2008","unstructured":"Aires da Silva, F., Corte-Real, S., Goncalves, J.: Recombinant antibodies as therapeutic agents: pathways for modeling new biodrugs. BioDrugs 22, 301\u2013314 (2008)","journal-title":"BioDrugs"},{"key":"24_CR5","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1089\/hum.2005.16.223","volume":"16","author":"F Aires da Silva","year":"2005","unstructured":"Aires da Silva, F., Costa, M.J.L., Corte-Real, S., Goncalves, J.: Cell type-specific targeting with sindbis pseudotyped lentiviral vectors displaying anti-CCR5 single-chain antibodies. Hum. Gene Ther. 16, 223\u2013234 (2005)","journal-title":"Hum. Gene Ther."},{"issue":"3","key":"24_CR6","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1016\/j.jmb.2004.04.062","volume":"340","author":"F Aires da Silva","year":"2004","unstructured":"Aires da Silva, F., Santa-Marta, M., Freitas-Vieira, A., Mascarenhas, P., Barahona, I., Moniz-Pereira, J., Gabuzda, D., Goncalves, J.: Camelized rabbit-derived VH single-domain intrabodies against Vif strongly neutralize HIV-1 infectivity. J. Mol. Biol. 340(3), 525\u2013542 (2004)","journal-title":"J. Mol. Biol."},{"key":"24_CR7","doi-asserted-by":"publisher","first-page":"2993","DOI":"10.1182\/blood-2010-07-298356","volume":"117","author":"W Alduaij","year":"2011","unstructured":"Alduaij, W., Illidge, T.M.: The future of anti-CD20 monoclonal antibodies: are we making progress? Blood 117, 2993\u20133001 (2011)","journal-title":"Blood"},{"key":"24_CR8","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1016\/j.rvsc.2014.07.009","volume":"97","author":"S Axiak-Bechtel","year":"2014","unstructured":"Axiak-Bechtel, S., Fowler, B., Yu, D.H., Amorim, J., Tsuruta, K., DeClue, A.: Chemotherapy and remission status do not alter pre-existing innate immune dysfunction in dogs with lymphoma. Res. Vet. Sci. 97, 230\u2013237 (2014)","journal-title":"Res. Vet. Sci."},{"key":"24_CR9","doi-asserted-by":"publisher","first-page":"7978","DOI":"10.1073\/pnas.88.18.7978","volume":"88","author":"CF Barbas","year":"1991","unstructured":"Barbas, C.F., Kang, A.S., Lerner, R.A., Benkovic, S.J.: Assembly of combinatorial antibody libraries on phage surfaces: the gene III site. Proc. Natl. Acad. Sci. U.S.A. 88, 7978\u20137982 (1991)","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"24_CR10","unstructured":"Barbas, C.F., Burton, D.R., Scott, J.K., Silverman, G.J.: Phage Display: A Laboratory Manual. CSHL Press (2004)"},{"key":"24_CR11","doi-asserted-by":"publisher","first-page":"799","DOI":"10.3390\/ijms19030799","volume":"19","author":"G Barutello","year":"2018","unstructured":"Barutello, G., Rolih, V., Arigoni, M., Tarone, L., Conti, L., Quaglino, E., Buracco, P., Cavallo, F., Riccardo, F.: Strengths and weaknesses of pre-clinical models for human melanoma treatment: dawn of dogs\u2019 revolution for immunotherapy. Int. J. Mol. Sci. 19, 799 (2018)","journal-title":"Int. J. Mol. Sci."},{"key":"24_CR12","first-page":"183","volume":"10","author":"F Biemar","year":"2013","unstructured":"Biemar, F., Foti, M.: Global progress against cancer\u2014challenges and opportunities. Cancer Biol. Med. 10, 183\u2013186 (2013)","journal-title":"Cancer Biol. Med."},{"key":"24_CR13","doi-asserted-by":"publisher","first-page":"2021","DOI":"10.1124\/dmd.112.046375","volume":"40","author":"RJ Boado","year":"2012","unstructured":"Boado, R.J., Hui, E.K.-W., Lu, J.Z., Pardridge, W.M.: Glycemic control and chronic dosing of rhesus monkeys with a fusion protein of iduronidase and a monoclonal antibody against the human insulin receptor. Drug Metab. Dispos. Biol. Fate Chem. 40, 2021\u20132025 (2012)","journal-title":"Drug Metab. Dispos. Biol. Fate Chem."},{"key":"24_CR14","doi-asserted-by":"publisher","first-page":"2317","DOI":"10.1002\/bit.25289","volume":"111","author":"RJ Boado","year":"2014","unstructured":"Boado, R.J., Ka-Wai Hui, E., Zhiqiang Lu, J., Pardridge, W.M.: Insulin receptor antibody-iduronate 2-sulfatase fusion protein: pharmacokinetics, anti-drug antibody, and safety pharmacology in Rhesus monkeys. Biotechnol. Bioeng. 111, 2317\u20132325 (2014)","journal-title":"Biotechnol. Bioeng."},{"key":"24_CR15","doi-asserted-by":"publisher","first-page":"1271","DOI":"10.1021\/acs.molpharmaceut.6b01166","volume":"14","author":"RJ Boado","year":"2017","unstructured":"Boado, R.J., Pardridge, W.M.: Brain and organ uptake in the rhesus monkey in vivo of recombinant iduronidase compared to an insulin receptor antibody-iduronidase fusion protein. Mol. Pharm. 14, 1271\u20131277 (2017)","journal-title":"Mol. Pharm."},{"key":"24_CR16","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1002\/bit.21120","volume":"96","author":"RJ Boado","year":"2007","unstructured":"Boado, R.J., Zhang, Y., Zhang, Y., Pardridge, W.M.: Humanization of anti-human insulin receptor antibody for drug targeting across the human blood-brain barrier. Biotechnol. Bioeng. 96, 381\u2013391 (2007)","journal-title":"Biotechnol. Bioeng."},{"key":"24_CR17","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1038\/nrd984","volume":"2","author":"OH Brekke","year":"2003","unstructured":"Brekke, O.H., Sandlie, I.: Therapeutic antibodies for human diseases at the dawn of the twenty-first century. Nat. Rev. Drug Discov. 2, 52\u201362 (2003)","journal-title":"Nat. Rev. Drug Discov."},{"key":"24_CR18","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1111\/j.1476-5381.2009.00190.x","volume":"157","author":"P Chames","year":"2009","unstructured":"Chames, P., Van Regenmortel, M., Weiss, E., Baty, D.: Therapeutic antibodies: successes, limitations and hopes for the future. Br. J. Pharmacol. 157, 220\u2013233 (2009)","journal-title":"Br. J. Pharmacol."},{"key":"24_CR19","doi-asserted-by":"publisher","first-page":"640","DOI":"10.1016\/j.addr.2011.11.010","volume":"64","author":"Y Chen","year":"2012","unstructured":"Chen, Y., Liu, L.: Modern methods for delivery of drugs across the blood\u2013brain barrier. Adv. Drug Deliv. Rev. 64, 640\u2013665 (2012)","journal-title":"Adv. Drug Deliv. Rev."},{"key":"24_CR20","doi-asserted-by":"publisher","first-page":"1691","DOI":"10.1097\/QAD.0000000000001108","volume":"30","author":"C Cunha-Santos","year":"2016","unstructured":"Cunha-Santos, C., Figueira, T.N., Borrego, P., Oliveira, S.S., Rocha, C., Couto, A., Cantante, C., Santos-Costa, Q., Azevedo-Pereira, J.M., Fontes, C.M.G.A., Taveira, N., Aires-Da-Silva, F., Castanho, M.A.R.B., Veiga, A.S., Goncalves, J.: Development of synthetic light-chain antibodies as novel and potent HIV fusion inhibitors. AIDS 30, 1691\u20131701 (2016)","journal-title":"AIDS"},{"key":"24_CR21","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1002\/bab.1034","volume":"59","author":"FA da Silva","year":"2012","unstructured":"da Silva, F.A., Li, M., Rato, S., Maia, S., Malh\u00f3, R., Warren, K., Harrich, D., Craigie, R., Barbas iii, C., Goncalves, J.: Recombinant rabbit single-chain antibodies bind to the catalytic and C-terminal domains of HIV-1 integrase protein and strongly inhibit HIV-1 replication. Biotechnol. Appl. Biochem. 59, 353\u2013366 (2012)","journal-title":"Biotechnol. Appl. Biochem."},{"key":"24_CR22","doi-asserted-by":"publisher","first-page":"32","DOI":"10.3390\/ph11020032","volume":"11","author":"N Dan","year":"2018","unstructured":"Dan, N., Setua, S., Kashyap, V.K., Khan, S., Jaggi, M., Yallapu, M.M., Chauhan, S.C.: Antibody-drug conjugates for cancer therapy: chemistry to clinical implications. Pharmaceuticals 11, 32 (2018)","journal-title":"Pharmaceuticals"},{"key":"24_CR23","doi-asserted-by":"publisher","first-page":"829","DOI":"10.3389\/fimmu.2017.00829","volume":"8","author":"WK Decker","year":"2017","unstructured":"Decker, W.K., da Silva, R.F., Sanabria, M.H., Angelo, L.S., Guimar\u00e3es, F., Burt, B.M., Kheradmand, F., Paust, S.: Cancer immunotherapy: historical perspective of a clinical revolution and emerging preclinical animal models. Front. Immunol. 8, 829 (2017)","journal-title":"Front. Immunol."},{"key":"24_CR24","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1038\/bjc.2015.435","volume":"114","author":"N Diamantis","year":"2016","unstructured":"Diamantis, N., Banerji, U.: Antibody-drug conjugates\u2014an emerging class of cancer treatment. Br. J. Cancer 114, 362\u2013367 (2016)","journal-title":"Br. J. Cancer"},{"key":"24_CR25","doi-asserted-by":"publisher","first-page":"28586","DOI":"10.18632\/oncotarget.25580","volume":"9","author":"JNR Dias","year":"2018","unstructured":"Dias, J.N.R., Aguiar, S.I., Pereira, D.M., Andr\u00e9, A.S., Gano, L., Correia, J.D.G., Carrapi\u00e7o, B., R\u00fctgen, B., Malh\u00f3, R., Peleteiro, C., Goncalves, J., Rodrigues, C.M.P., Gil, S., Tavares, L., Aires-da-Silva, F.: The histone deacetylase inhibitor panobinostat is a potent antitumor agent in canine diffuse large B-cell lymphoma. Oncotarget 9, 28586\u201328598 (2018a)","journal-title":"Oncotarget"},{"key":"24_CR26","doi-asserted-by":"publisher","first-page":"e0208147","DOI":"10.1371\/journal.pone.0208147","volume":"13","author":"JNR Dias","year":"2018","unstructured":"Dias, J.N.R., Andr\u00e9, A.S., Aguiar, S.I., Ministro, J., Oliveira, J., Peleteiro, C., R\u00fctgen, B., Gano, L., Correia, J.D.G., Oliveira, S.S., Goncalves, J., Gil, S., Tavares, L., Aires-Da-Silva, F.: Establishment of a bioluminescent canine B- cell lymphoma xenograft model for monitoring tumor progression and treatment response in preclinical studies. PLoS ONE 13, e0208147 (2018b)","journal-title":"PLoS ONE"},{"key":"24_CR27","doi-asserted-by":"publisher","first-page":"73","DOI":"10.2174\/157016210790416389","volume":"8","author":"JH Elder","year":"2010","unstructured":"Elder, J.H., Lin, Y.-C., Fink, E., Grant, C.K.: Feline immunodeficiency virus (FIV) as a model for study of lentivirus infections: parallels with HIV. Curr. HIV Res. 8, 73\u201380 (2010)","journal-title":"Curr. HIV Res."},{"key":"24_CR28","doi-asserted-by":"publisher","first-page":"4764","DOI":"10.1096\/fj.14-253369","volume":"28","author":"GK Farrington","year":"2014","unstructured":"Farrington, G.K., Caram-Salas, N., Haqqani, A.S., Brunette, E., Eldredge, J., Pepinsky, B., Antognetti, G., Baumann, E., Ding, W., Garber, E., Jiang, S., Delaney, C., Boileau, E., Sisk, W.P., Stanimirovic, D.B.: A novel platform for engineering blood-brain barrier-crossing bispecific biologics. FASEB J. 28, 4764\u20134778 (2014)","journal-title":"FASEB J."},{"key":"24_CR29","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1016\/j.nbd.2009.07.028","volume":"37","author":"R Gabathuler","year":"2010","unstructured":"Gabathuler, R.: Approaches to transport therapeutic drugs across the blood-brain barrier to treat brain diseases. Neurobiol. Dis. 37, 48\u201357 (2010)","journal-title":"Neurobiol. Dis."},{"key":"24_CR30","doi-asserted-by":"publisher","first-page":"1667","DOI":"10.3390\/molecules16021667","volume":"16","author":"Y Georgieva","year":"2011","unstructured":"Georgieva, Y., Konthur, Z.: Design and screening of M13 phage display cDNA libraries. Molecules 16, 1667\u20131681 (2011)","journal-title":"Molecules"},{"key":"24_CR31","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1186\/s13046-017-0668-0","volume":"36","author":"T Golan","year":"2017","unstructured":"Golan, T., Milella, M., Ackerstein, A., Berger, R.: The changing face of clinical trials in the personalized medicine and immuno-oncology era: report from the international congress on clinical trials in Oncology & Hemato-Oncology (ICTO 2017). J. Exp. Clin. Cancer Res. CR 36, 192 (2017)","journal-title":"J. Exp. Clin. Cancer Res. CR"},{"key":"24_CR32","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1038\/374168a0","volume":"374","author":"AS Greenberg","year":"1995","unstructured":"Greenberg, A.S., Avila, D., Hughes, M., Hughes, A., McKinney, E.C., Flajnik, M.F.: A new antigen receptor gene family that undergoes rearrangement and extensive somatic diversification in sharks. Nature 374, 168\u2013173 (1995)","journal-title":"Nature"},{"key":"24_CR33","doi-asserted-by":"publisher","first-page":"446","DOI":"10.1038\/363446a0","volume":"363","author":"C Hamers-Casterman","year":"1993","unstructured":"Hamers-Casterman, C., Atarhouch, T., Muyldermans, S., Robinson, G., Hamers, C., Songa, E.B., Hamers, R.: Naturally occurring antibodies devoid of light chains. Nature 363, 446\u2013448 (1993)","journal-title":"Nature"},{"key":"24_CR34","doi-asserted-by":"publisher","first-page":"1126","DOI":"10.1038\/nbt1142","volume":"23","author":"P Holliger","year":"2005","unstructured":"Holliger, P., Hudson, P.J.: Engineered antibody fragments and the rise of single domains. Nat. Biotechnol. 23, 1126\u20131136 (2005)","journal-title":"Nat. Biotechnol."},{"issue":"11","key":"24_CR35","doi-asserted-by":"publisher","first-page":"484","DOI":"10.1016\/j.tibtech.2003.08.007","volume":"21","author":"LJ Holt","year":"2003","unstructured":"Holt, L.J., Herring, C., Jespers, L.S., Woolven, B.P., Tomlinson, I.M.: Domain antibodies: proteins for therapy. Trends Biotechnol. 21(11), 484\u2013490 (2003)","journal-title":"Trends Biotechnol."},{"key":"24_CR36","doi-asserted-by":"publisher","first-page":"1105","DOI":"10.1038\/nbt1126","volume":"23","author":"HR Hoogenboom","year":"2005","unstructured":"Hoogenboom, H.R.: Selecting and screening recombinant antibody libraries. Nat. Biotechnol. 23, 1105\u20131116 (2005)","journal-title":"Nat. Biotechnol."},{"key":"24_CR37","doi-asserted-by":"publisher","first-page":"219","DOI":"10.3109\/10428194.2014.914193","volume":"56","author":"D Ito","year":"2015","unstructured":"Ito, D., Brewer, S., Modiano, J.F., Beall, M.J.: Development of a novel anti-canine CD20 monoclonal antibody with diagnostic and therapeutic potential. Leuk. Lymphoma 56, 219\u2013225 (2015)","journal-title":"Leuk. Lymphoma"},{"key":"24_CR38","doi-asserted-by":"publisher","first-page":"e0148366","DOI":"10.1371\/journal.pone.0148366","volume":"11","author":"S Jain","year":"2016","unstructured":"Jain, S., Aresu, L., Comazzi, S., Shi, J., Worrall, E., Clayton, J., Humphries, W., Hemmington, S., Davis, P., Murray, E., Limeneh, A.A., Ball, K., Ruckova, E., Muller, P., Vojtesek, B., Fahraeus, R., Argyle, D., Hupp, T.R.: The development of a recombinant scFv monoclonal antibody targeting canine CD20 for use in comparative medicine. PLoS ONE 11, e0148366 (2016)","journal-title":"PLoS ONE"},{"issue":"6382","key":"24_CR39","doi-asserted-by":"publisher","first-page":"1344","DOI":"10.1126\/science.359.6382.1344","volume":"359","author":"PN Kelly","year":"2018","unstructured":"Kelly, P.N.: The cancer immunotherapy revolution. Science 359(6382), 1344\u20131345 (2018)","journal-title":"Science"},{"key":"24_CR40","doi-asserted-by":"publisher","first-page":"133","DOI":"10.3389\/fimmu.2018.00133","volume":"9","author":"H Klingemann","year":"2018","unstructured":"Klingemann, H.: Immunotherapy for dogs: running behind humans. Front. Immunol. 9, 133 (2018)","journal-title":"Front. Immunol."},{"key":"24_CR41","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1038\/256495a0","volume":"256","author":"G K\u00f6hler","year":"1975","unstructured":"K\u00f6hler, G., Milstein, C.: Continuous cultures of fused cells secreting antibody of predefined specificity. Nature 256, 495\u2013497 (1975)","journal-title":"Nature"},{"key":"24_CR42","doi-asserted-by":"publisher","first-page":"22","DOI":"10.3389\/fonc.2017.00022","volume":"7","author":"R Kohnken","year":"2017","unstructured":"Kohnken, R., Porcu, P., Mishra, A.: Overview of the use of murine models in leukemia and lymphoma research. Front. Oncol. 7, 22 (2017)","journal-title":"Front. Oncol."},{"key":"24_CR43","doi-asserted-by":"publisher","first-page":"711","DOI":"10.1038\/nrd1470","volume":"3","author":"I Kola","year":"2004","unstructured":"Kola, I., Landis, J.: Can the pharmaceutical industry reduce attrition rates? Nat. Rev. Drug Discov. 3, 711\u2013716 (2004)","journal-title":"Nat. Rev. Drug Discov."},{"key":"24_CR44","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1146\/annurev-pharmtox-010814-124852","volume":"55","author":"JM Lajoie","year":"2015","unstructured":"Lajoie, J.M., Shusta, E.V.: Targeting receptor-mediated transport for delivery of biologics across the blood-brain barrier. Annu. Rev. Pharmacol. Toxicol. 55, 613\u2013631 (2015)","journal-title":"Annu. Rev. Pharmacol. Toxicol."},{"key":"24_CR45","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1007\/978-1-62703-977-2_19","volume":"1129","author":"M Levisson","year":"2014","unstructured":"Levisson, M., Spruijt, R.B., Winkel, I.N., Kengen, S.W.M., van der Oost, J.: Phage display of engineered binding proteins. Methods Mol. Biol. 1129, 211\u2013229 (2014)","journal-title":"Methods Mol. Biol."},{"key":"24_CR46","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1093\/ajh\/hpx011","volume":"30","author":"CA Lopez Gelston","year":"2017","unstructured":"Lopez Gelston, C.A., Mitchell, B.M.: Recent advances in immunity and hypertension. Am. J. Hypertens. 30, 643\u2013652 (2017)","journal-title":"Am. J. Hypertens."},{"key":"24_CR47","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.canlet.2013.10.010","volume":"344","author":"P Malaney","year":"2014","unstructured":"Malaney, P., Nicosia, S.V., Dav\u00e9, V.: One mouse, one patient paradigm: new avatars of personalized cancer therapy. Cancer Lett. 344, 1\u201312 (2014)","journal-title":"Cancer Lett."},{"key":"24_CR48","doi-asserted-by":"publisher","first-page":"668","DOI":"10.1158\/1078-0432.CCR-13-2283","volume":"20","author":"L Marconato","year":"2014","unstructured":"Marconato, L., Frayssinet, P., Rouquet, N., Comazzi, S., Leone, V.F., Laganga, P., Rossi, F., Vignoli, M., Pezzoli, L., Aresu, L.: Randomized, placebo-controlled, double-blinded chemoimmunotherapy clinical trial in a pet dog model of diffuse large b-cell lymphoma. Clin. Cancer Res. 20, 668\u2013677 (2014)","journal-title":"Clin. Cancer Res."},{"key":"24_CR49","doi-asserted-by":"publisher","first-page":"5080","DOI":"10.1016\/j.vaccine.2015.08.017","volume":"33","author":"L Marconato","year":"2015","unstructured":"Marconato, L., Stefanello, D., Sabattini, S., Comazzi, S., Riondato, F., Laganga, P., Frayssinet, P., Pizzoni, S., Rouque, N., Aresu, L.: Enhanced therapeutic effect of APAVAC immunotherapy in combination with dose-intense chemotherapy in dogs with advanced indolent B-cell lymphoma. Vaccine 33, 5080\u20135086 (2015)","journal-title":"Vaccine"},{"key":"24_CR50","doi-asserted-by":"publisher","first-page":"552","DOI":"10.1038\/348552a0","volume":"348","author":"J McCafferty","year":"1990","unstructured":"McCafferty, J., Griffiths, A.D., Winter, G., Chiswell, D.J.: Phage antibodies: filamentous phage displaying antibody variable domains. Nature 348, 552\u2013554 (1990)","journal-title":"Nature"},{"key":"24_CR51","doi-asserted-by":"crossref","unstructured":"Motta, G., Cea, M., Moran, E., Carbone, F., Augusti, V., Patrone, F., Nencioni, A.: Monoclonal antibodies for non-Hodgkin\u2019s lymphoma: state of the art and perspectives. Clin. Dev. Immunol. 2010 (2010)","DOI":"10.1155\/2010\/428253"},{"key":"24_CR52","doi-asserted-by":"publisher","first-page":"767","DOI":"10.1038\/nrd3229","volume":"9","author":"AL Nelson","year":"2010","unstructured":"Nelson, A.L., Dhimolea, E., Reichert, J.M.: Development trends for human monoclonal antibody therapeutics. Nat. Rev. Drug Discov. 9, 767\u2013774 (2010)","journal-title":"Nat. Rev. Drug Discov."},{"key":"24_CR53","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1016\/j.tibtech.2015.10.005","volume":"34","author":"V Neves","year":"2016","unstructured":"Neves, V., Aires-da-Silva, F., Corte-Real, S., Castanho, M.A.R.B.: Antibody approaches to treat brain diseases. Trends Biotechnol. 34, 36\u201348 (2016)","journal-title":"Trends Biotechnol."},{"key":"24_CR54","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/j.neuron.2013.10.061","volume":"81","author":"J Niewoehner","year":"2014","unstructured":"Niewoehner, J., Bohrmann, B., Collin, L., Urich, E., Sade, H., Maier, P., Rueger, P., Stracke, J.O., Lau, W., Tissot, A.C., Loetscher, H., Ghosh, A., Freskg\u00e5rd, P.-O.: Increased brain penetration and potency of a therapeutic antibody using a monovalent molecular shuttle. Neuron 81, 49\u201360 (2014)","journal-title":"Neuron"},{"key":"24_CR55","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1093\/ilar\/ilu020","volume":"55","author":"CM O\u2019Connor","year":"2014","unstructured":"O\u2019Connor, C.M., Wilson-Robles, H.: Developing T cell cancer immunotherapy in the dog with lymphoma. ILAR J. Natl. Res. Counc. Inst. Lab. Anim. Resour. 55, 169\u2013181 (2014)","journal-title":"ILAR J. Natl. Res. Counc. Inst. Lab. Anim. Resour."},{"key":"24_CR56","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1002\/bab.1011","volume":"59","author":"SS Oliveira","year":"2012","unstructured":"Oliveira, S.S., Aires da Silva, F., Lourenco, S., Freitas-Vieira, A., Cunha Santos, A.C., Goncalves, J.: Assessing combinatorial strategies to multimerize libraries of single-domain antibodies. Biotechnol. Appl. Biochem. 59, 193\u2013204 (2012)","journal-title":"Biotechnol. Appl. Biochem."},{"key":"24_CR57","doi-asserted-by":"publisher","first-page":"807","DOI":"10.1023\/A:1016244500596","volume":"12","author":"WM Pardridge","year":"1995","unstructured":"Pardridge, W.M., Kang, Y.S., Buciak, J.L., Yang, J.: Human insulin receptor monoclonal antibody undergoes high affinity binding to human brain capillaries in vitro and rapid transcytosis through the blood-brain barrier in vivo in the primate. Pharm. Res. 12, 807\u2013816 (1995)","journal-title":"Pharm. Res."},{"key":"24_CR58","doi-asserted-by":"publisher","first-page":"1959","DOI":"10.1038\/jcbfm.2012.126","volume":"32","author":"WM Pardridge","year":"2012","unstructured":"Pardridge, W.M.: Drug transport across the blood\u2013brain barrier. J. Cereb. Blood Flow Metab. 32, 1959\u20131972 (2012)","journal-title":"J. Cereb. Blood Flow Metab."},{"key":"24_CR59","doi-asserted-by":"publisher","first-page":"963","DOI":"10.1517\/17425247.2016.1171315","volume":"13","author":"WM Pardridge","year":"2016","unstructured":"Pardridge, W.M.: CSF, blood-brain barrier, and brain drug delivery. Expert Opin. Drug Deliv. 13, 963\u2013975 (2016)","journal-title":"Expert Opin. Drug Deliv."},{"key":"24_CR60","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1007\/s40259-017-0248-z","volume":"31","author":"WM Pardridge","year":"2017","unstructured":"Pardridge, W.M.: Delivery of biologics across the blood-brain barrier with molecular trojan horse technology. BioDrugs 31, 503\u2013519 (2017)","journal-title":"BioDrugs"},{"key":"24_CR61","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1016\/B978-0-12-396962-0.00011-2","volume":"503","author":"William M Pardridge","year":"2012","unstructured":"Pardridge, William M., Boado, R.J.: Reengineering biopharmaceuticals for targeted delivery across the blood-brain barrier. Methods Enzymol. 503, 269\u2013292 (2012)","journal-title":"Methods Enzymol."},{"key":"24_CR62","doi-asserted-by":"publisher","first-page":"1559","DOI":"10.1038\/mt.2010.104","volume":"18","author":"D Peruzzi","year":"2010","unstructured":"Peruzzi, D., Gavazza, A., Mesiti, G., Lubas, G., Scarselli, E., Conforti, A., Bendtsen, C., Ciliberto, G., La Monica, N., Aurisicchio, L.: A vaccine targeting telomerase enhances survival of dogs affected by B-cell lymphoma. Mol. Ther. 18, 1559\u20131567 (2010)","journal-title":"Mol. Ther."},{"key":"24_CR63","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1016\/S0022-2836(02)01232-9","volume":"325","author":"M Popkov","year":"2003","unstructured":"Popkov, M., Mage, R.G., Alexander, C.B., Thundivalappil, S., Barbas, C.F., Rader, C.: Rabbit immune repertoires as sources for therapeutic monoclonal antibodies: the impact of kappa allotype-correlated variation in cysteine content on antibody libraries selected by phage display. J. Mol. Biol. 325, 325\u2013335 (2003)","journal-title":"J. Mol. Biol."},{"key":"24_CR64","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1016\/j.jmb.2012.01.038","volume":"417","author":"H Qi","year":"2012","unstructured":"Qi, H., Lu, H., Qiu, H.-J., Petrenko, V., Liu, A.: Phagemid vectors for phage display: properties, characteristics and construction. J. Mol. Biol. 417, 129\u2013143 (2012)","journal-title":"J. Mol. Biol."},{"key":"24_CR65","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1016\/S0958-1669(97)80075-4","volume":"8","author":"C Rader","year":"1997","unstructured":"Rader, C., Barbas, C.F.: Phage display of combinatorial antibody libraries. Curr. Opin. Biotechnol. 8, 503\u2013508 (1997)","journal-title":"Curr. Opin. Biotechnol."},{"key":"24_CR66","doi-asserted-by":"publisher","first-page":"13668","DOI":"10.1074\/jbc.275.18.13668","volume":"275","author":"C Rader","year":"2000","unstructured":"Rader, C., Ritter, G., Nathan, S., Elia, M., Gout, I., Jungbluth, A.A., Cohen, L.S., Welt, S., Old, L.J., Barbas, C.F.: The rabbit antibody repertoire as a novel source for the generation of therapeutic human antibodies. J. Biol. Chem. 275, 13668\u201313676 (2000)","journal-title":"J. Biol. Chem."},{"key":"24_CR67","doi-asserted-by":"publisher","first-page":"423","DOI":"10.3390\/vetsci2040423","volume":"2","author":"D Regan","year":"2015","unstructured":"Regan, D., Dow, S.: Manipulation of innate immunity for cancer therapy in dogs. Vet. Sci. 2, 423\u2013439 (2015)","journal-title":"Vet. Sci."},{"key":"24_CR68","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1016\/j.vetimm.2015.02.004","volume":"164","author":"SM Rue","year":"2015","unstructured":"Rue, S.M., Eckelman, B.P., Efe, J.A., Bloink, K., Deveraux, Q.L., Lowery, D., Nasoff, M.: Identification of a candidate therapeutic antibody for treatment of canine B-cell lymphoma. Vet. Immunol. Immunopathol. 164, 148\u2013159 (2015)","journal-title":"Vet. Immunol. Immunopathol."},{"key":"24_CR69","first-page":"1749","volume":"8","author":"E Salvati","year":"2013","unstructured":"Salvati, E., Re, F., Sesana, S., Cambianica, I., Sancini, G., Masserini, M., Gregori, M.: Liposomes functionalized to overcome the blood-brain barrier and to target amyloid-\u03b2 peptide: the chemical design affects the permeability across an in vitro model. Int. J. Nanomed. 8, 1749\u20131758 (2013)","journal-title":"Int. J. Nanomed."},{"issue":"43","key":"24_CR70","doi-asserted-by":"publisher","first-page":"11261","DOI":"10.1073\/pnas.1716187114","volume":"114","author":"HH Shen","year":"2017","unstructured":"Shen, H.H.: Core concept: circumventing the blood-brain barrier. Proc. Natl. Acad. Sci. U.S.A. 114(43), 11261\u201311263 (2017)","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"24_CR71","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1038\/nbt.2793","volume":"32","author":"G Sinha","year":"2014","unstructured":"Sinha, G.: Companion therapeutics. Nat. Biotechnol. 32, 12\u201314 (2014)","journal-title":"Nat. Biotechnol."},{"key":"24_CR72","doi-asserted-by":"publisher","first-page":"1315","DOI":"10.1126\/science.4001944","volume":"228","author":"GP Smith","year":"1985","unstructured":"Smith, G.P.: Filamentous fusion phage: novel expression vectors that display cloned antigens on the virion surface. Science 228, 1315\u20131317 (1985)","journal-title":"Science"},{"key":"24_CR73","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1038\/nature23301","volume":"548","author":"D Sok","year":"2017","unstructured":"Sok, D., Le, K.M., Vadnais, M., Saye-Francisco, K.L., Jardine, J.G., Torres, J.L., Berndsen, Z.T., Kong, L., Stanfield, R., Ruiz, J., Ramos, A., Liang, C.-H., Chen, P.L., Criscitiello, M.F., Mwangi, W., Wilson, I.A., Ward, A.B., Smider, V.V., Burton, D.R.: Rapid elicitation of broadly neutralizing antibodies to HIV by immunization in cows. Nature 548, 108\u2013111 (2017)","journal-title":"Nature"},{"key":"24_CR74","doi-asserted-by":"publisher","first-page":"36073","DOI":"10.1074\/jbc.M002765200","volume":"275","author":"P Steinberger","year":"2000","unstructured":"Steinberger, P., Sutton, J.K., Rader, C., Elia, M., Barbas, C.F.: Generation and characterization of a recombinant human CCR5-specific antibody. A phage display approach for rabbit antibody humanization. J. Biol. Chem. 275, 36073\u201336078 (2000)","journal-title":"J. Biol. Chem."},{"key":"24_CR75","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1007\/s13238-017-0457-8","volume":"9","author":"WR Strohl","year":"2017","unstructured":"Strohl, W.R.: Current progress in innovative engineered antibodies. Protein Cell 9, 86\u2013120 (2017)","journal-title":"Protein Cell"},{"key":"24_CR76","doi-asserted-by":"crossref","unstructured":"Strohl, W.R., Strohl, L.M. (eds.): 15 - Antibody-drug conjugates. In: Therapeutic Antibody Engineering, pp. 345\u2013595. Woodhead Publishing (2012)","DOI":"10.1533\/9781908818096.345"},{"key":"24_CR77","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1016\/j.cimid.2013.07.001","volume":"36","author":"SA Taniwaki","year":"2013","unstructured":"Taniwaki, S.A., Figueiredo, A.S., Araujo, J.P.: Virus-host interaction in feline immunodeficiency virus (FIV) infection. Comp. Immunol. Microbiol. Infect. Dis. 36, 549\u2013557 (2013)","journal-title":"Comp. Immunol. Microbiol. Infect. Dis."},{"key":"24_CR78","doi-asserted-by":"crossref","unstructured":"Vail, D.M., Young, K.M., Pinkerton, M.E.: Chapter 31 - Hematopoietic Tumors. In: Withrow, S., Vail, D., Page, R. (eds.) Withrow & MacEwen\u2019s Small Animal Clinical Oncology, 4th edn., pp. 699\u2013784. W.B. Saunders, Saint Louis (2007)","DOI":"10.1016\/B978-072160558-6.50034-4"},{"key":"24_CR79","doi-asserted-by":"publisher","first-page":"141","DOI":"10.4155\/tde-2016-0002","volume":"7","author":"M Vankemmelbeke","year":"2016","unstructured":"Vankemmelbeke, M., Durrant, L.: Third-generation antibody drug conjugates for cancer therapy \u2013 a balancing act. Ther. Deliv. 7, 141\u2013144 (2016)","journal-title":"Ther. Deliv."},{"key":"24_CR80","first-page":"514","volume":"42","author":"CL Ventola","year":"2017","unstructured":"Ventola, C.L.: Cancer immunotherapy, part 3: challenges and future trends. Pharm. Ther. 42, 514\u2013521 (2017)","journal-title":"Pharm. Ther."},{"key":"24_CR81","doi-asserted-by":"publisher","first-page":"e305","DOI":"10.1038\/emm.2017.23","volume":"49","author":"J Weber","year":"2017","unstructured":"Weber, J., Peng, H., Rader, C.: From rabbit antibody repertoires to rabbit monoclonal antibodies. Exp. Mol. Med. 49, e305 (2017)","journal-title":"Exp. Mol. Med."},{"key":"24_CR82","doi-asserted-by":"publisher","first-page":"1072","DOI":"10.1158\/2326-6066.CIR-16-0105","volume":"4","author":"K Weiskopf","year":"2016","unstructured":"Weiskopf, K., Anderson, K.L., Ito, D., Schnorr, P.J., Tomiyasu, H., Ring, A.M., Bloink, K., Efe, J., Rue, S., Lowery, D., Barkal, A., Prohaska, S., McKenna, K.M., Cornax, I., O\u2019Brien, T.D., O\u2019Sullivan, M.G., Weissman, I.L., Modiano, J.F.: Eradication of canine diffuse large B-cell lymphoma in a murine xenograft model with CD47 blockade and anti-CD20. Cancer Immunol. Res. 4, 1072\u20131087 (2016)","journal-title":"Cancer Immunol. Res."},{"key":"24_CR83","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1146\/annurev.iy.12.040194.002245","volume":"12","author":"G Winter","year":"1994","unstructured":"Winter, G., Griffiths, A.D., Hawkins, R.E., Hoogenboom, H.R.: Making antibodies by phage display technology. Annu. Rev. Immunol. 12, 433\u2013455 (1994)","journal-title":"Annu. Rev. Immunol."},{"key":"24_CR84","doi-asserted-by":"publisher","first-page":"1804","DOI":"10.1172\/JCI119708","volume":"100","author":"D Wu","year":"1997","unstructured":"Wu, D., Yang, J., Pardridge, W.M.: Drug targeting of a peptide radiopharmaceutical through the primate blood-brain barrier in vivo with a monoclonal antibody to the human insulin receptor. J. Clin. Invest. 100, 1804\u20131812 (1997)","journal-title":"J. Clin. Invest."},{"key":"24_CR85","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1002\/jgm.1152","volume":"10","author":"C-F Xia","year":"2008","unstructured":"Xia, C.-F., Boado, R.J., Zhang, Y., Chu, C., Pardridge, W.M.: Intravenous glial-derived neurotrophic factor gene therapy of experimental Parkinson\u2019s disease with Trojan horse liposomes and a tyrosine hydroxylase promoter. J. Gene Med. 10, 306\u2013315 (2008)","journal-title":"J. Gene Med."},{"issue":"7","key":"24_CR86","doi-asserted-by":"publisher","first-page":"1274","DOI":"10.2215\/CJN.10031014","volume":"10","author":"KM Yatim","year":"2015","unstructured":"Yatim, K.M., Lakkis, F.G.: A brief journey through the immune system. Clin. J. Am. Soc. Nephrol. CJASN 10(7), 1274\u20131281 (2015)","journal-title":"Clin. J. Am. Soc. Nephrol. CJASN"},{"key":"24_CR87","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1126\/scitranslmed.3002230","volume":"3","author":"YJ Yu","year":"2011","unstructured":"Yu, Y.J., Zhang, Y., Kenrick, M., Hoyte, K., Luk, W., Lu, Y., Atwal, J., Elliott, J.M., Prabhu, S., Watts, R.J., Dennis, M.S.: Boosting brain uptake of a therapeutic antibody by reducing its affinity for a transcytosis target. Sci. Transl. Med. 3, 84 (2011)","journal-title":"Sci. Transl. Med."},{"key":"24_CR88","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/S1525-0016(02)00018-7","volume":"7","author":"Y Zhang","year":"2003","unstructured":"Zhang, Y., Schlachetzki, F., Pardridge, W.M.: Global non-viral gene transfer to the primate brain following intravenous administration. Mol. Ther. 7, 11\u201318 (2003)","journal-title":"Mol. Ther."}],"container-title":["Advances in Animal Health, Medicine and Production"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/978-3-030-61981-7_24","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,11,21]],"date-time":"2020-11-21T15:28:50Z","timestamp":1605972530000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/978-3-030-61981-7_24"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020]]},"ISBN":["9783030619800","9783030619817"],"references-count":88,"URL":"https:\/\/doi.org\/10.1007\/978-3-030-61981-7_24","relation":{},"subject":[],"published":{"date-parts":[[2020]]},"assertion":[{"value":"22 November 2020","order":1,"name":"first_online","label":"First Online","group":{"name":"ChapterHistory","label":"Chapter History"}}]}}